In matter related to patent dispute with Bracco DiagnosticsJubilant Pharma, a subsidiary of Jubilant Pharmova, announced
that it has received a favorable and unanimous judgment from the United States Court of Appeals summarily affirming Jubilant's earlier favorable rulings from the US Patent Office (PTAB) and the US International Trade
Commission (ITC). These two rulings by the Appellate Court deny the appeals filed by Bracco Diagnostics, Inc (Bracco).
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office as well as in a separate proceeding in the ITC. In both instances, Jubilant was successful.